A dimer peptide ligand of vascular endothelial growth factor slows the progression of human gastric tumors in mouse xenografts
Xiaoqing Ye, Haofeng Hu, Yilei He, Fei Ye, Jia Jin, Elodie Olivier, Jean-François Gaucher, Lei Wang · 2026
Read A dimer peptide ligand of vascular endothelial growth factor slows the progression of human gastric tumors in mouse xenografts by Xiaoqing Ye, Haofeng Hu, Yilei He, Fei Ye, Jia Jin, Elodie Olivier, Jean-François Gaucher, Lei Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0344142.txt.
Description
Xiaoqing Ye and seven colleagues published this 2026 cancer study testing a small peptide against stomach tumors. Drugs that block the growth factor VEGF can slow new blood vessels feeding a tumor, but the antibody versions are large and reach tissue poorly. A doubled peptide called D6, designed to grip VEGF, was their smaller alternative.
In cell tests and in mice carrying human stomach tumors, D6 slowed growth about as well as the standard antibody used for comparison. The catch was dose: the peptide needed repeated injections at higher amounts. Ye's group is now refining the molecule toward a more practical treatment.
Catalog record
| CREATOR | Xiaoqing Ye, Haofeng Hu, Yilei He, Fei Ye, Jia Jin, Elodie Olivier, Jean-François Gaucher, Lei Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26603 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |